

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.12173628 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.12173628 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.80081620 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.80081620 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.31169796 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.84670981 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.63000380 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.63000380 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.63000380 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.53254840 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.48030641 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.37103406 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36815015 |
| 14 | urea cycle (GO:0000050) | 5.34528303 |
| 15 | urea metabolic process (GO:0019627) | 5.34528303 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.31667018 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22207998 |
| 18 | cysteine metabolic process (GO:0006534) | 5.20282437 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.14741215 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.06195019 |
| 21 | regulation of cholesterol esterification (GO:0010872) | 5.05707833 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.01096599 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.92727924 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.90107361 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.87332912 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.85989369 |
| 27 | protein carboxylation (GO:0018214) | 4.85989369 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.83780845 |
| 29 | response to nitrosative stress (GO:0051409) | 4.71317180 |
| 30 | bile acid metabolic process (GO:0008206) | 4.70038272 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.63547410 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.61114241 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.60953962 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.59335883 |
| 35 | regulation of complement activation (GO:0030449) | 4.53791314 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.53349264 |
| 37 | lysine catabolic process (GO:0006554) | 4.47933303 |
| 38 | lysine metabolic process (GO:0006553) | 4.47933303 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.46843241 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.44795660 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.44795660 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44795660 |
| 43 | benzene-containing compound metabolic process (GO:0042537) | 4.43857535 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.42768086 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.42768086 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.35780558 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.30981596 |
| 48 | cellular glucuronidation (GO:0052695) | 4.29446161 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.27100542 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.27100542 |
| 51 | glutamate metabolic process (GO:0006536) | 4.26622178 |
| 52 | phospholipid efflux (GO:0033700) | 4.26009230 |
| 53 | xenobiotic catabolic process (GO:0042178) | 4.18951966 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.17158092 |
| 55 | drug catabolic process (GO:0042737) | 4.09042351 |
| 56 | regulation of cholesterol homeostasis (GO:2000188) | 4.06168270 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.05484018 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.02932575 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.02900669 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.02437657 |
| 61 | regulation of bile acid biosynthetic process (GO:0070857) | 4.01449667 |
| 62 | bile acid and bile salt transport (GO:0015721) | 3.99960084 |
| 63 | cholesterol efflux (GO:0033344) | 3.97148548 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96563504 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 3.94724850 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.90322215 |
| 67 | glycine metabolic process (GO:0006544) | 3.86804260 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.84782424 |
| 69 | uronic acid metabolic process (GO:0006063) | 3.84782424 |
| 70 | positive regulation of p38MAPK cascade (GO:1900745) | 3.82482059 |
| 71 | amine catabolic process (GO:0009310) | 3.80696450 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 3.80696450 |
| 73 | activation of MAPKKK activity (GO:0000185) | 3.77175395 |
| 74 | arginine metabolic process (GO:0006525) | 3.72911401 |
| 75 | omega-hydroxylase P450 pathway (GO:0097267) | 3.72789217 |
| 76 | epoxygenase P450 pathway (GO:0019373) | 3.71173673 |
| 77 | phospholipid homeostasis (GO:0055091) | 3.70151355 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.70020889 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.69522083 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.69397055 |
| 81 | fibrinolysis (GO:0042730) | 3.64340643 |
| 82 | exogenous drug catabolic process (GO:0042738) | 3.63859063 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63613847 |
| 84 | urate metabolic process (GO:0046415) | 3.63298590 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.62685717 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.61851103 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.59232688 |
| 88 | ketone body metabolic process (GO:1902224) | 3.57824864 |
| 89 | sterol homeostasis (GO:0055092) | 3.57000207 |
| 90 | drug transmembrane transport (GO:0006855) | 3.56942391 |
| 91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52998079 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.52921488 |
| 93 | organic acid catabolic process (GO:0016054) | 3.52921488 |
| 94 | ethanol oxidation (GO:0006069) | 3.50869159 |
| 95 | regulation of p38MAPK cascade (GO:1900744) | 3.49669520 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.44449378 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.44449378 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.43644860 |
| 99 | acetyl-CoA metabolic process (GO:0006084) | 3.43623870 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40085100 |
| 101 | acute-phase response (GO:0006953) | 3.39941793 |
| 102 | drug metabolic process (GO:0017144) | 3.38374036 |
| 103 | short-chain fatty acid metabolic process (GO:0046459) | 3.35918727 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.34986254 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.34426557 |
| 106 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.18487177 |
| 107 | response to mercury ion (GO:0046689) | 3.15958629 |
| 108 | regulation of plasminogen activation (GO:0010755) | 3.11826493 |
| 109 | sodium ion export (GO:0071436) | 3.10154684 |
| 110 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.05422578 |
| 111 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.01531768 |
| 112 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.93462568 |
| 113 | complement activation (GO:0006956) | 2.91793746 |
| 114 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.86091320 |
| 115 | protein activation cascade (GO:0072376) | 2.85201245 |
| 116 | atrioventricular valve morphogenesis (GO:0003181) | 2.83972320 |
| 117 | negative regulation of lipid transport (GO:0032369) | 2.79526359 |
| 118 | tooth mineralization (GO:0034505) | 2.79447945 |
| 119 | opsonization (GO:0008228) | 2.69812967 |
| 120 | cell-cell junction maintenance (GO:0045217) | 2.69071922 |
| 121 | activation of protein kinase A activity (GO:0034199) | 2.66637737 |
| 122 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.65907892 |
| 123 | negative regulation of fatty acid transport (GO:2000192) | 2.65114181 |
| 124 | regulation of humoral immune response (GO:0002920) | 2.63150309 |
| 125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.60843163 |
| 126 | cAMP biosynthetic process (GO:0006171) | 2.60424188 |
| 127 | endothelial cell chemotaxis (GO:0035767) | 2.59439407 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 2.57928817 |
| 129 | regulation of cholesterol metabolic process (GO:0090181) | 2.56721309 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.53833442 |
| 131 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50671020 |
| 132 | cellular potassium ion homeostasis (GO:0030007) | 2.50182029 |
| 133 | positive regulation of cholesterol efflux (GO:0010875) | 2.46553448 |
| 134 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.44288444 |
| 135 | positive regulation of hemostasis (GO:1900048) | 2.44038723 |
| 136 | positive regulation of blood coagulation (GO:0030194) | 2.44038723 |
| 137 | gas transport (GO:0015669) | 2.42823374 |
| 138 | intestinal cholesterol absorption (GO:0030299) | 2.42155378 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.41731719 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.38434012 |
| 141 | cellular sodium ion homeostasis (GO:0006883) | 2.38068656 |
| 142 | surfactant homeostasis (GO:0043129) | 2.37498513 |
| 143 | fructose metabolic process (GO:0006000) | 2.35922730 |
| 144 | negative regulation of blood coagulation (GO:0030195) | 2.35633389 |
| 145 | negative regulation of hemostasis (GO:1900047) | 2.35633389 |
| 146 | positive regulation of coagulation (GO:0050820) | 2.32616865 |
| 147 | oxygen transport (GO:0015671) | 2.31432870 |
| 148 | cerebellar granule cell differentiation (GO:0021707) | 2.30258976 |
| 149 | proline metabolic process (GO:0006560) | 2.29047395 |
| 150 | hyaluronan metabolic process (GO:0030212) | 2.28935890 |
| 151 | phosphate ion transmembrane transport (GO:0035435) | 2.28887140 |
| 152 | regulation of apoptotic cell clearance (GO:2000425) | 2.28800238 |
| 153 | embryonic process involved in female pregnancy (GO:0060136) | 2.26714435 |
| 154 | gluconeogenesis (GO:0006094) | 2.26641977 |
| 155 | regulation of lipid catabolic process (GO:0050994) | 2.26427677 |
| 156 | creatine metabolic process (GO:0006600) | 2.25962668 |
| 157 | adherens junction assembly (GO:0034333) | 2.25906484 |
| 158 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25843172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.44592944 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.33602581 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.85358894 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.54615291 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.90023617 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.23469483 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.96915105 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.88857630 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.15247844 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.01655092 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.50120410 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34704824 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.28022707 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21888302 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10231794 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.05574224 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02214115 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3674368 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98079552 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.95427806 |
| 21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90603988 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89199626 |
| 23 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.87474659 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79021673 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.77906727 |
| 26 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.75294712 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72329983 |
| 28 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66042701 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62822996 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60358752 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55030763 |
| 32 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49575722 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47136277 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.46717371 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45637211 |
| 36 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.43662096 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.43571623 |
| 38 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42125617 |
| 39 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38948035 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36355008 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35848305 |
| 42 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35828382 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34435818 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32493240 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29560223 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28920532 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27804709 |
| 48 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24767726 |
| 49 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24000259 |
| 50 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.22784525 |
| 51 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22626023 |
| 52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22089109 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20497653 |
| 54 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19834086 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16814016 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16576589 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16301457 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16247290 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16085927 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15963586 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13835691 |
| 62 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13025073 |
| 63 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.12947264 |
| 64 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12718067 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11790077 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09852643 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09852643 |
| 68 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09365424 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08807427 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08670807 |
| 71 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08566209 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08347279 |
| 73 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.05393895 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05182297 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05130773 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04675232 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03386245 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01815792 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00218797 |
| 80 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99409574 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98905436 |
| 82 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98064075 |
| 83 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96841143 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96206514 |
| 85 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94898590 |
| 86 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94433460 |
| 87 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94055246 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93981752 |
| 89 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93971924 |
| 90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92484367 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92484367 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92294694 |
| 93 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.92139221 |
| 94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91414859 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86981008 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86566010 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86566010 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84383818 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83998610 |
| 100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82993953 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81392962 |
| 102 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81060419 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79900709 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79377474 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74802272 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74161760 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72385848 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72265614 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72264382 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71006363 |
| 111 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70321442 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.69665011 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.69537826 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.69487691 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69093955 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68717439 |
| 117 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.68099380 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66379894 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63222056 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61352409 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.60524044 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60146103 |
| 123 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59770737 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.59522663 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59467323 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.59033486 |
| 127 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58755627 |
| 128 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.57766577 |
| 129 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.57247906 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.56795108 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55905598 |
| 132 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.55696017 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.55680208 |
| 134 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.55141327 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.54761297 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.54651099 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.54599857 |
| 138 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.53474090 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52754852 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50436435 |
| 141 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.50304519 |
| 142 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50140763 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.49986350 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.49695759 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49455700 |
| 146 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.48423807 |
| 147 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47891576 |
| 148 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47669704 |
| 149 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47655635 |
| 150 | KDM2B_26808549_Chip-Seq_K562_Human | 0.46124782 |
| 151 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.45729391 |
| 152 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.45584533 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.45463245 |
| 154 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.45351146 |
| 155 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.45319720 |
| 156 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.45233095 |
| 157 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44609819 |
| 158 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44541750 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44504116 |
| 160 | CBP_21632823_ChIP-Seq_H3396_Human | 0.44495088 |
| 161 | RXR_22108803_ChIP-Seq_LS180_Human | 0.43963451 |
| 162 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43672383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.03521792 |
| 2 | MP0005360_urolithiasis | 7.39630792 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.21008176 |
| 4 | MP0005365_abnormal_bile_salt | 6.02999442 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.43806428 |
| 6 | MP0003252_abnormal_bile_duct | 3.91489986 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.58107712 |
| 8 | MP0009840_abnormal_foam_cell | 3.28621986 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.21858246 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02827089 |
| 11 | MP0005332_abnormal_amino_acid | 2.89472339 |
| 12 | MP0003195_calcinosis | 2.76754675 |
| 13 | MP0003879_abnormal_hair_cell | 2.69919825 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.38932548 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.38399427 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.37744650 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.33228073 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.17493430 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.14111148 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.11134407 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.07834431 |
| 22 | MP0000609_abnormal_liver_physiology | 2.06428160 |
| 23 | MP0001502_abnormal_circadian_rhythm | 1.92935480 |
| 24 | MP0000751_myopathy | 1.81180020 |
| 25 | MP0003303_peritoneal_inflammation | 1.77653266 |
| 26 | MP0003453_abnormal_keratinocyte_physiol | 1.71598036 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.71174763 |
| 28 | MP0004233_abnormal_muscle_weight | 1.68607361 |
| 29 | MP0004858_abnormal_nervous_system | 1.65272157 |
| 30 | MP0003868_abnormal_feces_composition | 1.61871767 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.61170058 |
| 32 | MP0002249_abnormal_larynx_morphology | 1.60378713 |
| 33 | MP0001764_abnormal_homeostasis | 1.59841411 |
| 34 | MP0005409_darkened_coat_color | 1.58184441 |
| 35 | MP0002254_reproductive_system_inflammat | 1.49583551 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48959934 |
| 37 | MP0000747_muscle_weakness | 1.48902430 |
| 38 | MP0004270_analgesia | 1.45200383 |
| 39 | MP0004510_myositis | 1.40353241 |
| 40 | MP0003705_abnormal_hypodermis_morpholog | 1.38179133 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.31728503 |
| 42 | MP0003011_delayed_dark_adaptation | 1.30610649 |
| 43 | MP0005451_abnormal_body_composition | 1.30291038 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.30243908 |
| 45 | MP0003091_abnormal_cell_migration | 1.30240084 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.28304425 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.24609194 |
| 48 | MP0004185_abnormal_adipocyte_glucose | 1.23896828 |
| 49 | MP0004947_skin_inflammation | 1.15636490 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.14346290 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.12906676 |
| 52 | MP0000604_amyloidosis | 1.12419155 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.10504450 |
| 54 | MP0003186_abnormal_redox_activity | 1.09122271 |
| 55 | MP0000598_abnormal_liver_morphology | 1.04170862 |
| 56 | MP0009697_abnormal_copulation | 1.01824251 |
| 57 | MP0004043_abnormal_pH_regulation | 1.00542181 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.00148087 |
| 59 | MP0009764_decreased_sensitivity_to | 0.99583940 |
| 60 | MP0001958_emphysema | 0.99272055 |
| 61 | MP0000750_abnormal_muscle_regeneration | 0.97577066 |
| 62 | MP0005647_abnormal_sex_gland | 0.97509190 |
| 63 | MP0003690_abnormal_glial_cell | 0.96901765 |
| 64 | MP0000733_abnormal_muscle_development | 0.94374714 |
| 65 | MP0005535_abnormal_body_temperature | 0.93317765 |
| 66 | MP0003634_abnormal_glial_cell | 0.92830726 |
| 67 | MP0010368_abnormal_lymphatic_system | 0.90924673 |
| 68 | MP0005636_abnormal_mineral_homeostasis | 0.90076018 |
| 69 | MP0005670_abnormal_white_adipose | 0.89012246 |
| 70 | MP0005501_abnormal_skin_physiology | 0.88709940 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.88119049 |
| 72 | MP0003329_amyloid_beta_deposits | 0.87520153 |
| 73 | MP0009278_abnormal_bone_marrow | 0.87421886 |
| 74 | MP0003635_abnormal_synaptic_transmissio | 0.86976070 |
| 75 | MP0004130_abnormal_muscle_cell | 0.86767841 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.86624088 |
| 77 | MP0009763_increased_sensitivity_to | 0.86374690 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 0.85233643 |
| 79 | MP0001756_abnormal_urination | 0.84911939 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.83972797 |
| 81 | MP0008260_abnormal_autophagy | 0.83575906 |
| 82 | MP0005023_abnormal_wound_healing | 0.83054938 |
| 83 | MP0002971_abnormal_brown_adipose | 0.81689754 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.81351087 |
| 85 | MP0008569_lethality_at_weaning | 0.78494892 |
| 86 | MP0001849_ear_inflammation | 0.78322518 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.77902007 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.77678845 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.77345030 |
| 90 | MP0001188_hyperpigmentation | 0.77318465 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.77144864 |
| 92 | MP0002269_muscular_atrophy | 0.74955122 |
| 93 | MP0003878_abnormal_ear_physiology | 0.73922715 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.73922715 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.73678791 |
| 96 | MP0002822_catalepsy | 0.73582994 |
| 97 | MP0005334_abnormal_fat_pad | 0.72975354 |
| 98 | MP0003828_pulmonary_edema | 0.72710176 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.72103390 |
| 100 | MP0008872_abnormal_physiological_respon | 0.70872675 |
| 101 | MP0003436_decreased_susceptibility_to | 0.70055916 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.69282539 |
| 103 | MP0009053_abnormal_anal_canal | 0.69057387 |
| 104 | MP0000749_muscle_degeneration | 0.68854724 |
| 105 | MP0001915_intracranial_hemorrhage | 0.68690207 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.68658037 |
| 107 | MP0008469_abnormal_protein_level | 0.68624776 |
| 108 | MP0005408_hypopigmentation | 0.68506652 |
| 109 | MP0000343_altered_response_to | 0.67866528 |
| 110 | MP0002089_abnormal_postnatal_growth/wei | 0.67299872 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.66613621 |
| 112 | MP0002090_abnormal_vision | 0.66450105 |
| 113 | MP0002064_seizures | 0.66129824 |
| 114 | MP0004272_abnormal_basement_membrane | 0.65800001 |
| 115 | MP0005448_abnormal_energy_balance | 0.62466608 |
| 116 | MP0002928_abnormal_bile_duct | 0.61185321 |
| 117 | MP0003075_altered_response_to | 0.61169788 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.60807955 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.58293286 |
| 120 | MP0005266_abnormal_metabolism | 0.56981602 |
| 121 | MP0006036_abnormal_mitochondrial_physio | 0.56919754 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.55222531 |
| 123 | MP0005187_abnormal_penis_morphology | 0.53657958 |
| 124 | MP0005166_decreased_susceptibility_to | 0.52960777 |
| 125 | MP0004883_abnormal_blood_vessel | 0.50343735 |
| 126 | MP0003953_abnormal_hormone_level | 0.50336962 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.50167533 |
| 128 | MP0008874_decreased_physiological_sensi | 0.49127869 |
| 129 | MP0003724_increased_susceptibility_to | 0.45869799 |
| 130 | MP0001501_abnormal_sleep_pattern | 0.44627429 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.43612511 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.43504287 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.43096873 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.42823969 |
| 135 | MP0001661_extended_life_span | 0.41779081 |
| 136 | MP0002168_other_aberrant_phenotype | 0.41606668 |
| 137 | MP0005395_other_phenotype | 0.41556640 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.40814951 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.40085932 |
| 140 | MP0008873_increased_physiological_sensi | 0.40073450 |
| 141 | MP0005248_abnormal_Harderian_gland | 0.39889924 |
| 142 | MP0005167_abnormal_blood-brain_barrier | 0.39361070 |
| 143 | MP0009115_abnormal_fat_cell | 0.39233302 |
| 144 | MP0002796_impaired_skin_barrier | 0.38395115 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.37936378 |
| 146 | MP0010234_abnormal_vibrissa_follicle | 0.37688111 |
| 147 | MP0009672_abnormal_birth_weight | 0.37574603 |
| 148 | MP0005164_abnormal_response_to | 0.36067106 |
| 149 | MP0003633_abnormal_nervous_system | 0.35512996 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.35403396 |
| 151 | MP0000579_abnormal_nail_morphology | 0.35187969 |
| 152 | MP0003300_gastrointestinal_ulcer | 0.34744864 |
| 153 | MP0001765_abnormal_ion_homeostasis | 0.32909703 |
| 154 | MP0004782_abnormal_surfactant_physiolog | 0.31177873 |
| 155 | MP0005464_abnormal_platelet_physiology | 0.30943450 |
| 156 | MP0002837_dystrophic_cardiac_calcinosis | 0.30552702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.12837789 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.91976902 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.69733821 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60393975 |
| 5 | Xanthomatosis (HP:0000991) | 6.33881133 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.89893249 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.79280030 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.24859946 |
| 9 | Complement deficiency (HP:0004431) | 5.02058418 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.60668378 |
| 11 | Epidermoid cyst (HP:0200040) | 4.57466104 |
| 12 | Hyperammonemia (HP:0001987) | 4.39665706 |
| 13 | Hyperglycinemia (HP:0002154) | 4.34890453 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.32417582 |
| 15 | Joint hemorrhage (HP:0005261) | 4.30182644 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.27138598 |
| 17 | Ketosis (HP:0001946) | 4.25482346 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.16678467 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13651625 |
| 20 | Hyperglycinuria (HP:0003108) | 4.09530216 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.02076928 |
| 22 | Fat malabsorption (HP:0002630) | 3.93167136 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90554040 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.90554040 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.80444568 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.69009118 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.66668338 |
| 28 | Abnormality of complement system (HP:0005339) | 3.64888702 |
| 29 | Gout (HP:0001997) | 3.51971003 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.44794766 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.38380019 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35800311 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.27616931 |
| 34 | Ketoacidosis (HP:0001993) | 3.24822926 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.17859614 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13588035 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.06573588 |
| 38 | Myocardial infarction (HP:0001658) | 3.03804665 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.01449298 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00283605 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.96249688 |
| 42 | Exercise-induced myalgia (HP:0003738) | 2.94865098 |
| 43 | Spontaneous abortion (HP:0005268) | 2.91395647 |
| 44 | Hyperbilirubinemia (HP:0002904) | 2.91377369 |
| 45 | Steatorrhea (HP:0002570) | 2.89221191 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.85403923 |
| 47 | Increased connective tissue (HP:0009025) | 2.85142382 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.84387826 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.83007860 |
| 50 | Myopathic facies (HP:0002058) | 2.81014082 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.79803478 |
| 52 | Skin nodule (HP:0200036) | 2.79322486 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.74806479 |
| 54 | Ulnar bowing (HP:0003031) | 2.71674434 |
| 55 | Metabolic acidosis (HP:0001942) | 2.71015119 |
| 56 | Obstructive sleep apnea (HP:0002870) | 2.70909030 |
| 57 | Achilles tendon contracture (HP:0001771) | 2.69214257 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.66723243 |
| 59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.57923017 |
| 60 | Irritability (HP:0000737) | 2.51618969 |
| 61 | Turricephaly (HP:0000262) | 2.51317134 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.48502153 |
| 63 | Mitral stenosis (HP:0001718) | 2.47272205 |
| 64 | Reticulocytosis (HP:0001923) | 2.44969589 |
| 65 | Neonatal onset (HP:0003623) | 2.44641859 |
| 66 | Vascular calcification (HP:0004934) | 2.42530959 |
| 67 | Spastic diplegia (HP:0001264) | 2.41138125 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.40525516 |
| 69 | Acanthocytosis (HP:0001927) | 2.39870609 |
| 70 | Lethargy (HP:0001254) | 2.38472518 |
| 71 | Thin bony cortex (HP:0002753) | 2.37175140 |
| 72 | Sensorimotor neuropathy (HP:0007141) | 2.35322127 |
| 73 | Nephritis (HP:0000123) | 2.30649364 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.28876115 |
| 75 | Amyloidosis (HP:0011034) | 2.28132706 |
| 76 | Glomerulonephritis (HP:0000099) | 2.27547929 |
| 77 | Increased purine levels (HP:0004368) | 2.26675939 |
| 78 | Hyperuricemia (HP:0002149) | 2.26675939 |
| 79 | Esophageal varix (HP:0002040) | 2.26457022 |
| 80 | Cholelithiasis (HP:0001081) | 2.25091519 |
| 81 | Lower limb amyotrophy (HP:0007210) | 2.24950200 |
| 82 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24291934 |
| 83 | Malnutrition (HP:0004395) | 2.23796102 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 2.21883947 |
| 85 | Cholecystitis (HP:0001082) | 2.21839033 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.21839033 |
| 87 | Rickets (HP:0002748) | 2.18155892 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17428973 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.17428973 |
| 90 | Axonal loss (HP:0003447) | 2.16964595 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 2.16908355 |
| 92 | Status epilepticus (HP:0002133) | 2.15120391 |
| 93 | Cardiovascular calcification (HP:0011915) | 2.13473844 |
| 94 | Hypercortisolism (HP:0001578) | 2.12467226 |
| 95 | Neuronal loss in central nervous system (HP:0002529) | 2.11772794 |
| 96 | Foot dorsiflexor weakness (HP:0009027) | 2.11306930 |
| 97 | Generalized aminoaciduria (HP:0002909) | 2.10871962 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.09934696 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.09934696 |
| 100 | Late onset (HP:0003584) | 2.09793374 |
| 101 | Muscle fiber inclusion bodies (HP:0100299) | 2.09308928 |
| 102 | Pancreatitis (HP:0001733) | 2.08936291 |
| 103 | Enlarged kidneys (HP:0000105) | 2.06210681 |
| 104 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02996044 |
| 105 | Hyperacusis (HP:0010780) | 2.02531488 |
| 106 | Abnormality of nail color (HP:0100643) | 2.02192849 |
| 107 | Hemorrhage of the eye (HP:0011885) | 2.00676676 |
| 108 | Alkalosis (HP:0001948) | 2.00112216 |
| 109 | Round ear (HP:0100830) | 1.99652377 |
| 110 | Hyperglycemia (HP:0003074) | 1.99344731 |
| 111 | Broad face (HP:0000283) | 1.98420894 |
| 112 | Cerebral aneurysm (HP:0004944) | 1.97917438 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97869995 |
| 114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97502203 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 1.96019836 |
| 116 | Cerebral edema (HP:0002181) | 1.94566912 |
| 117 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93197184 |
| 118 | Bulbar palsy (HP:0001283) | 1.92688880 |
| 119 | Vomiting (HP:0002013) | 1.92284257 |
| 120 | Onion bulb formation (HP:0003383) | 1.91705792 |
| 121 | Menorrhagia (HP:0000132) | 1.90456627 |
| 122 | Atrioventricular block (HP:0001678) | 1.90099029 |
| 123 | Brushfield spots (HP:0001088) | 1.89419468 |
| 124 | Pigmentary retinal degeneration (HP:0001146) | 1.89093518 |
| 125 | Abnormality of the Achilles tendon (HP:0005109) | 1.88738378 |
| 126 | Gingival bleeding (HP:0000225) | 1.88336381 |
| 127 | Distal upper limb amyotrophy (HP:0007149) | 1.86794616 |
| 128 | Upper limb amyotrophy (HP:0009129) | 1.86794616 |
| 129 | Abnormality of the foot musculature (HP:0001436) | 1.84877876 |
| 130 | Abnormality of the gallbladder (HP:0005264) | 1.84488685 |
| 131 | Thrombophlebitis (HP:0004418) | 1.84186465 |
| 132 | Poikilocytosis (HP:0004447) | 1.83939414 |
| 133 | Myokymia (HP:0002411) | 1.83539763 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.82085545 |
| 135 | EMG: myopathic abnormalities (HP:0003458) | 1.81987913 |
| 136 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.79892544 |
| 137 | Polycythemia (HP:0001901) | 1.79073575 |
| 138 | Dysmetric saccades (HP:0000641) | 1.78730420 |
| 139 | Hyporeflexia of lower limbs (HP:0002600) | 1.78540668 |
| 140 | Insomnia (HP:0100785) | 1.77370754 |
| 141 | Death in childhood (HP:0003819) | 1.77336001 |
| 142 | Confusion (HP:0001289) | 1.76501739 |
| 143 | Hammertoe (HP:0001765) | 1.76199802 |
| 144 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76159904 |
| 145 | Spinal rigidity (HP:0003306) | 1.74734963 |
| 146 | Abnormal cartilage morphology (HP:0002763) | 1.74260542 |
| 147 | Nemaline bodies (HP:0003798) | 1.74087660 |
| 148 | Diaphragmatic weakness (HP:0009113) | 1.73543903 |
| 149 | Ulnar claw (HP:0001178) | 1.72744738 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.71725009 |
| 151 | Neonatal hypoglycemia (HP:0001998) | 1.70208760 |
| 152 | Distal sensory impairment (HP:0002936) | 1.69980179 |
| 153 | Hyperparathyroidism (HP:0000843) | 1.69452547 |
| 154 | Asymmetric septal hypertrophy (HP:0001670) | 1.68781165 |
| 155 | Abnormality of the fingertips (HP:0001211) | 1.68312764 |
| 156 | Stroke (HP:0001297) | 1.66767071 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66143468 |
| 158 | Ankle clonus (HP:0011448) | 1.65725161 |
| 159 | Muscle fiber splitting (HP:0003555) | 1.65433222 |
| 160 | Annular pancreas (HP:0001734) | 1.63996661 |
| 161 | Difficulty running (HP:0009046) | 1.63913897 |
| 162 | Stridor (HP:0010307) | 1.63452468 |
| 163 | Bowel incontinence (HP:0002607) | 1.63196527 |
| 164 | Difficulty climbing stairs (HP:0003551) | 1.62648876 |
| 165 | Long palpebral fissure (HP:0000637) | 1.61091034 |
| 166 | Abnormal atrioventricular conduction (HP:0005150) | 1.60686501 |
| 167 | Rapidly progressive (HP:0003678) | 1.59176556 |
| 168 | Overgrowth (HP:0001548) | 1.58065694 |
| 169 | Ragged-red muscle fibers (HP:0003200) | 1.57429226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.23884262 |
| 2 | FGFR4 | 4.15142896 |
| 3 | ERN1 | 3.67551278 |
| 4 | SIK1 | 3.64475136 |
| 5 | ERBB4 | 2.76876375 |
| 6 | PRPF4B | 2.66854891 |
| 7 | INSRR | 2.63701253 |
| 8 | ICK | 2.48876888 |
| 9 | MAP2K4 | 2.42136660 |
| 10 | DAPK2 | 2.07276768 |
| 11 | TAOK3 | 2.02459364 |
| 12 | TTN | 1.87551410 |
| 13 | CDK12 | 1.81409762 |
| 14 | RIPK1 | 1.79769966 |
| 15 | PINK1 | 1.78379962 |
| 16 | TRIB3 | 1.74319131 |
| 17 | NTRK2 | 1.71176654 |
| 18 | IRAK3 | 1.64604817 |
| 19 | PIM2 | 1.60630733 |
| 20 | MST1R | 1.59472274 |
| 21 | EEF2K | 1.58192523 |
| 22 | MARK2 | 1.55867738 |
| 23 | MAP3K3 | 1.44840535 |
| 24 | MAP3K4 | 1.44175687 |
| 25 | MAPK15 | 1.42564860 |
| 26 | ARAF | 1.41154238 |
| 27 | PTK6 | 1.37186458 |
| 28 | BRAF | 1.34225036 |
| 29 | SGK3 | 1.34002611 |
| 30 | EPHA3 | 1.31825121 |
| 31 | SGK2 | 1.30925916 |
| 32 | MAPK11 | 1.29949783 |
| 33 | MAP3K2 | 1.27347501 |
| 34 | SMG1 | 1.25185041 |
| 35 | EPHB1 | 1.23433030 |
| 36 | ERBB2 | 1.23289537 |
| 37 | FRK | 1.22545006 |
| 38 | SGK494 | 1.22137735 |
| 39 | SGK223 | 1.22137735 |
| 40 | JAK2 | 1.21520077 |
| 41 | LATS1 | 1.17758860 |
| 42 | TAOK1 | 1.15616113 |
| 43 | ABL2 | 1.15504384 |
| 44 | PKN2 | 1.15441694 |
| 45 | RPS6KA2 | 1.14508347 |
| 46 | EPHA4 | 1.12698342 |
| 47 | JAK1 | 1.10999249 |
| 48 | TYK2 | 1.10495944 |
| 49 | TAOK2 | 1.09492941 |
| 50 | OBSCN | 1.08605023 |
| 51 | CDC42BPA | 1.06810861 |
| 52 | LATS2 | 1.04790301 |
| 53 | PRKAA2 | 1.02197618 |
| 54 | MAP3K9 | 1.02172819 |
| 55 | SIK2 | 1.01585945 |
| 56 | MAP3K7 | 1.01014898 |
| 57 | PRKCZ | 0.98659780 |
| 58 | STK38L | 0.98421725 |
| 59 | GSK3A | 0.97015971 |
| 60 | MAP3K14 | 0.96711311 |
| 61 | PDGFRA | 0.95203333 |
| 62 | STK38 | 0.94447206 |
| 63 | NEK9 | 0.91374988 |
| 64 | MAP2K3 | 0.89835523 |
| 65 | FGFR2 | 0.88077996 |
| 66 | RPS6KC1 | 0.86946407 |
| 67 | RPS6KL1 | 0.86946407 |
| 68 | IRAK2 | 0.86341372 |
| 69 | EPHB2 | 0.82793185 |
| 70 | MOS | 0.82332713 |
| 71 | PRKAA1 | 0.81055987 |
| 72 | MAP2K2 | 0.79364605 |
| 73 | PDPK1 | 0.79222143 |
| 74 | TBK1 | 0.76552673 |
| 75 | MAPK12 | 0.75855189 |
| 76 | RET | 0.75082822 |
| 77 | PDK4 | 0.74820012 |
| 78 | PDK3 | 0.74820012 |
| 79 | PIK3CG | 0.73963570 |
| 80 | BLK | 0.73905842 |
| 81 | KSR2 | 0.73453877 |
| 82 | CAMK2G | 0.72987811 |
| 83 | PTK2 | 0.71659021 |
| 84 | FER | 0.71582776 |
| 85 | MAPK4 | 0.71438392 |
| 86 | RPS6KA6 | 0.71257880 |
| 87 | PRKACG | 0.70724236 |
| 88 | PRKD2 | 0.70070728 |
| 89 | GRK6 | 0.69377373 |
| 90 | DMPK | 0.68310768 |
| 91 | NTRK1 | 0.67646673 |
| 92 | NEK6 | 0.67124649 |
| 93 | PAK3 | 0.66969427 |
| 94 | MAP2K1 | 0.66954682 |
| 95 | PAK6 | 0.66399355 |
| 96 | MAP3K1 | 0.66099618 |
| 97 | FGFR3 | 0.66024938 |
| 98 | PDK2 | 0.65867411 |
| 99 | TYRO3 | 0.64449261 |
| 100 | DYRK1B | 0.60798603 |
| 101 | WNK3 | 0.60722457 |
| 102 | MAP3K6 | 0.60581388 |
| 103 | DDR2 | 0.59686395 |
| 104 | MAP3K11 | 0.59213907 |
| 105 | RPS6KA1 | 0.56856849 |
| 106 | PRKCG | 0.55334762 |
| 107 | MAPK7 | 0.54993202 |
| 108 | RAF1 | 0.53645568 |
| 109 | BRD4 | 0.52934596 |
| 110 | UHMK1 | 0.52260292 |
| 111 | CAMK1D | 0.52046640 |
| 112 | PAK2 | 0.51861013 |
| 113 | TIE1 | 0.51661454 |
| 114 | MAP3K10 | 0.51196977 |
| 115 | GRK1 | 0.49974877 |
| 116 | EPHA2 | 0.49027297 |
| 117 | AKT3 | 0.48115078 |
| 118 | CAMK4 | 0.47993397 |
| 119 | IKBKE | 0.47879874 |
| 120 | CAMKK1 | 0.47490817 |
| 121 | NTRK3 | 0.47319432 |
| 122 | HIPK2 | 0.46694024 |
| 123 | PDK1 | 0.46204529 |
| 124 | MAP2K6 | 0.45381812 |
| 125 | MAPK10 | 0.45140948 |
| 126 | CAMK1 | 0.44830004 |
| 127 | KDR | 0.44814854 |
| 128 | IRAK1 | 0.44087233 |
| 129 | PRKCH | 0.44011984 |
| 130 | MINK1 | 0.43877507 |
| 131 | MTOR | 0.43791440 |
| 132 | BMX | 0.43769667 |
| 133 | SGK1 | 0.42481574 |
| 134 | PRKD3 | 0.42345748 |
| 135 | AKT2 | 0.41455745 |
| 136 | MAP3K13 | 0.41279547 |
| 137 | PHKG2 | 0.39932104 |
| 138 | PHKG1 | 0.39932104 |
| 139 | MARK1 | 0.39608425 |
| 140 | CDK5 | 0.38976820 |
| 141 | RIPK4 | 0.38706163 |
| 142 | STK11 | 0.35766243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28182073 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.78007412 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.56365994 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39480262 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07732970 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54374957 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53858623 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50789007 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49447464 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38890841 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36036476 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34982204 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.30415414 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27138796 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23278164 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.09765617 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.08424156 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.90140781 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88360427 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88009176 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81307168 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77827462 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73304954 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71808816 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70100284 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.68759924 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65350104 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59940807 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56750424 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52223313 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52011244 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50268288 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46812794 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46773658 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37842196 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37811815 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37304341 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32207743 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30583645 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28991253 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26814917 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25162180 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.24009308 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.19879862 |
| 45 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.11734481 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11525652 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09220936 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09154147 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.06051905 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04251214 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03750707 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03553758 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02606107 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00985104 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98650778 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98390659 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96655160 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96287637 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94537498 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90547817 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89655931 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89056703 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88551794 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84307644 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84164205 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.82767783 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82296597 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80733514 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79104141 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.78720464 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77102471 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76362104 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.75824203 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75424766 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74942001 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74403424 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.72735210 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72691827 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71951197 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71825153 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71501141 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71089239 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70136517 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66396814 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66173522 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61720738 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58659669 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58109908 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55743183 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52319781 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.50634101 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.48567413 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48533679 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48228952 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47966570 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47485070 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46924948 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46169794 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45905950 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45715467 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.45132009 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45078831 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45054506 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44109806 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43615062 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43054219 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42147045 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42066071 |
| 109 | Gap junction_Homo sapiens_hsa04540 | 0.41899789 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41785585 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41172596 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36443757 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32325929 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29794553 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.27398447 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25162689 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23854390 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15275659 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11759734 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10567374 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09153401 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.06993434 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.04567683 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02259941 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00670990 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.00632326 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1487474 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1475439 |
| 129 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1468039 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1466728 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.1424788 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | -0.1387918 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | -0.1262902 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1225548 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0823715 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0562594 |
| 137 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0560883 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0456949 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0432313 |
| 140 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0299890 |
| 141 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0118361 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0073300 |

